Navigation Links
Nuclear stress test can detect more than blockages
Date:7/14/2008

"

Dr. Patel collaborated with Dr. Vincent J.B. Robinson and looked at 52 consecutive patients who underwent cardiac catheterization within 15 days of a nuclear stress test to test the efficacy in diagnosing diastolic dysfunction.

During a nuclear stress test, radioactive thallium is injected into the bloodstream to show how well blood flows to the heart muscle. Scans are taken shortly after an exercise test to show blood flow when the heart is stressed and two or three hours later to show blood flow during rest.

"This test is usually used to identify blockages in the heart," Dr. Patel explains. "But in addition to the blockages, we have demonstrated that it also shows the left ventricle filling pressure, thus giving us an excellent prognostic value in predicting diastolic dysfunction because when the filling pressure is too high, the left ventricle has a hard time receiving blood."

Dr. Patel and the MCG nuclear cardiology research team compared the diastolic filling pressure from the catheterization and from the nuclear stress test and found that the latter had a 94 percent specificity in detecting diastolic dysfunction (i.e. high filling pressure at cardiac catheterization).

The nuclear stress test plots out a heartbeat in 16 frames, and that represents the diastolic filling curve at 16 points, like taking a melon and slicing it into 16 even pieces, says Dr. Robinson, nuclear cardiologist at MCG and the Charlie Norwood Veterans Affairs Medical Center of Augusta and faculty adviser on the study. The slope of the filling portion of the curve is a representation of the left ventricle filling pressure used as a marker of diastolic dysfunction.

"We have discovered that just looking at these markers can tell us whether a patient has diastolic dysfunction or not," says Dr. Robinson. "Diastolic function is a major prognostic factor in these patients with coronary disease. Previously, the nuclear stress test was on
'/>"/>

Contact: Amy Connell
aconnell@mcg.edu
706-721-8605
Medical College of Georgia
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Advertising Hall of Famer Charles D. Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy
2. Study recommends development of standards for pediatric doses in nuclear medicine
3. DOE Seeks Licensing Approval for Yucca Mountain Nuclear Waste Storage Site
4. SNM hosts 55th Annual Meeting of Nuclear Medicine and Molecular Imaging Research
5. HRSA Outreach Seeks to Raise Cancer Awareness Among People Who Lived Near Nuclear Sites or Mined Uranium
6. Sutter Opens Countys First Non-Hospital-Based Nuclear Imaging Option
7. Western Reserve Heart Care Receives ICANL Nuclear Medicine Accreditation
8. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
9. CardiacQA Surpasses 20,000 Client Generated Nuclear Cardiology Reports
10. Patients need to know that nuclear medicine procedures can trigger radiation alarms
11. Oosight Imaging System Enables a Breakthrough: The Viable Transfer of Genetic Material for Stem Cell Nuclear Reprogramming in Primates
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nuclear stress test can detect more than blockages
Nuclear stress test can detect more than blockages
(Date:1/8/2009)..., ALEXANDRIA, Va., Jan. 8 /PRNewswire-USNewswire/ ... Organization along with several national leadersh...rding the principles of hospice care and protectio...ns standing together in sharing this unified messa...tion of Hospice and Palliative Medicine, Hospice a...
(Date:1/8/2009)..., California Assembly Member Tom Torlakson Introdu...swire-USNewswire/ -- Today, Lung Cancer Alliance...ember Tom Torlakson (D-11th District) for his cont...ing funding for lung cancer research. For the thi...ung cancer research is being considered in the Cal...
(Date:1/8/2009)...view says it lowered bad cholesterol more effectiv...lthDay News) -- After nearly a year of review, U.S...ed the continued use of the controversial choleste...Drug Administration said there was no significant ...ients taking Vytorin and patients taking the drug ...
(Date:1/8/2009)..., First Announced Acquisition in 2009 Continues Gr... IPC The Hospitalist Comp...spitalist physician group practice company, announ...ctice of Midwest Acute Care Consultants, Inc. (MAC...nts continued expansion in the St. Louis market, w...
Breaking Medicine News(10 mins):Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2
...ational TB Control Programme (RNTCP) aims at widen...uality treatment and diagnostic services to all tu...0 % of HIV-positive people are more prone to contr...amily Welfare Minister Anbumani Ramadoss plan to t...
...nducted by Steven M. Kurtz, of Exponent Inc., a Ph...ting firm//, there is an increase in demand for ar...artificial joints needed to replace damaged knees ...e study showed that the demand for artificial hips...
...ts had captured the market and minds of various pe...iny. // A number of detox products are to be inve... report by the BBC which drew its attention to som...he Medical Health Care Products Regulatory Agency ...
...ar, Nitish Kumar assured that the Bihar Government...ing spread of AIDS/HIV in the state //, addressing...ma foundation, Samyak and the National Aids Contro...oncern over the explosive prevalence of HIV/AIDS i...
Other Medicine News:Health News:India to Implement National Action Plan against TB-HIV 2
(Date:1/8/2009)...o, Jan. 8 IntelligentMDx a develope...ays, today announced that verification studies of ... complete. , , Under the verification protocol...d reproducibility and robustness of the BK Viral Q... agreed with internally generated analytical perfo...
(Date:1/7/2009)...re-FirstCall/ -- Eli Lilly and Company,(NYSE: L...esponse letter from,the U.S. Food and Drug Admini...on (LAI) for acute and maintenance treatment of sc...k with the agency on the new drug,application (ND...al clinical trials for the continued,review of th...
(Date:1/7/2009)...rease , , WHITE PLAINS, N.Y., Jan. 7 /PRNewswir... that the decades-long rise in the United States p...than ever at increased risk of death and disabilit...43,000 babies were born too soon in 2006, accordin...ich today released "Births: Final data for 2006," ...
(Date:1/7/2009)...opment Based On Osteotech,s Proprietary Human Coll...on; FDA Filing Anticipated in Third Quarter 2009 ...ll/ -- Osteotech, Inc. (Nasdaq: OSTE ), a lead...regenerative healing, announced today that it has ...h(TM) BioRegeneration Matrix. The first five patie...
Breaking Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6Preterm Births Rise 36 Percent Since Early 1980s 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3MINRAD International Inc Announces FDA Approval of Petrem 28TM 29 Sevoflurane 21372 1MINRAD International Inc Announces FDA Approval of Petrem 28TM 29 Sevoflurane 21372 2Congressional Leaders and Mens Health Network Emphasize the Importance of Health During the 15th Annual National Mens Health Week 21370 1Congressional Leaders and Mens Health Network Emphasize the Importance of Health During the 15th Annual National Mens Health Week 21370 2Consumer Reports 3A Patients Overdose on Debt As Lenders Doctors and Hospitals Push Risky Credit to Pay for Medical Care 21368 1Consumer Reports 3A Patients Overdose on Debt As Lenders Doctors and Hospitals Push Risky Credit to Pay for Medical Care 21368 2Consumer Reports 3A Patients Overdose on Debt As Lenders Doctors and Hospitals Push Risky Credit to Pay for Medical Care 21368 3Consumer Reports 3A Patients Overdose on Debt As Lenders Doctors and Hospitals Push Risky Credit to Pay for Medical Care 21368 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ 004 28Staccato 28R 29 Loxapine 29 for Acute Agitation 2375 1Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ 004 28Staccato 28R 29 Loxapine 29 for Acute Agitation 2375 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ 004 28Staccato 28R 29 Loxapine 29 for Acute Agitation 2375 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ 004 28Staccato 28R 29 Loxapine 29 for Acute Agitation 2375 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ 004 28Staccato 28R 29 Loxapine 29 for Acute Agitation 2375 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ 004 28Staccato 28R 29 Loxapine 29 for Acute Agitation 2375 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ 004 28Staccato 28R 29 Loxapine 29 for Acute Agitation 2375 7
...ently approved by FDA for long-term maintenance,tr...ate first,nebulized formoterol fumarate provides i...moterol, enhanced patient quality of,life, and pos...7 /PRNewswire/ -- Data presented at the,Internatio...TS),demonstrate that Perforomist (formoterol fumar...
...ivolol Lowers Blood Pressure in Obese and,Non-Obes...Newswire-FirstCall/ -- Forest,Laboratories, Inc. t...dies and one pooled analysis of nebivolol, a selec...urrently under review by,the U.S. Food and Drug Ad...on. Data from the two clinical studies show that,n...
Other Medicine Technology:Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 2Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 3Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 4
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Medicine Products: